Join Vaccine World Asia Congress 2021Download Brochure
Showcase Your Solutions
Thought Leadership, Product Showcase, Lead Generation, Branding and Other Opportunities Available!Download Sponsorship Prospectus
Explore Endless Learning & Networking Opportunities On Our Virtual Event Platform!Download Brochure
Due to increasing healthcare expenditure, advancing vaccine technology, and rising demand for preventives vaccines, especially new COVID-19 vaccines, the Asia-Pacific preventive vaccines market will rise by 12.89% annually with a total addressable market cap of $97.2 billion between 2020 and 2026.
Coronavirus infection has recently infected millions of people all over the world. In certain areas, community transmission has resulted in an increase in global casualties. At present, Big pharma and biopharma are concentrating their efforts on COVID-19 vaccine research and development. The COVID-19 pandemic situation has generated unprecedented demand, and companies are heavily investing in R&D activities, with government support as well as technological advancement to shorten the clinical trial duration and increase production efficiency. The market's growth prospects will be bolstered by the expansion of vaccine manufacturing facilities to meet the rising demand.
Vaccine World Asia Congress 2021 will be the only vaccine-focused platform in Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the Big Pharmas, International Biopharma, Asian Biopharma, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers, and Technocrats.
With this edition of Vaccine World Asia, we have co-located with Asia-Pacific Vaccine Excellence Awards. If Asia’s vaccine business matters to you, then Vaccine World Asia Congress 2021 is the place to be!
Vaccine World Asia Congress will be the only vaccine focused platform in Singapore for Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the BIG Pharmas, International Biopharma’s, Asian Biopharmas, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers and Technocrats. If Asia’s vaccines business matters to you, then Vaccine World Asia 2021 is the place to be!
Tedros Adhanom Ghebreyesus WHO
Dr. David Dodd GeoVax
Dr. Alexandre Le Vert OSIVAX
Dr. Jakob Cramer CEPI
Jeffrey Wolf Heat Biologics
Amgad Gamil Pfizer
Dr. Dina Berdieva Bill & Melinda Gates Medical Research Institute
Frederic Ors IMV Inc
Jorge Fragoso Sanofi Pasteur
ShouBai Chou CanSino Biologics
Nikolai Petrovsky Vaxine Pty Ltd
Dr. Ashish Sahai Serum Institute of India
Dr. Ingrid Kromann CEPI
Kevin Wang Beijing CC-Pharming
Dr. Ajoy Chakrabati Bill & Melinda Gates Foundation
Dr. Raghavan Varadarajan Indian Institute of Science
Dr. Alexandre Le Vert OSIVAX
Dr. Tzyy-Choou Wu Johns Hopkins University School of Medicine
Prof Maria Elena Bottazzi Baylor College of Medicine
Dr. Lily Wu Papivax
Dr. Jean-Louis Excler International Vaccine Institute
Dr. Shweta Chatrath IAVI
Dr. Ramesh Matur Biological E Ltd
Pierre A. Morgon Eurocine Vaccines, NED, Vaccitech, NED, Univercells
Sanjay Singh Gennova Biopharmaceuticals Ltd, India
Dr. Asel Sartbaeva University of Bath
Prof Vasan Vasan
Dr. Ashraf Mohammadi Razi Vaccine & Serum Research Institute
Dr. Arindam Ray Bill & Melinda Gates Foundation
Dr. Raj Shankar Ghosh Bill and Melinda Gates Foundation
Vaccine World Asia Congress 2021 will provide you with the opportunity to educate the market about your offerings and position yourselves as leaders in your field alongside key industry figures! This is an EXCEPTIONAL opportunity to position your brand and business before the Asia’s top vaccine executives. Make sure you get access to the region’s hottest life science sub-sector.